Keywords: Hyperpolarized MR (Non-Gas), Hyperpolarized MR (Non-Gas)
Motivation: Metabolic impairment is key in Alzheimer’s disease (AD) and metabolic imaging has high potential to improve AD diagnosis and monitoring.
Goal(s): Our goal is to assess whether hyperpolarized 13C MR spectroscopy (MRS) can detect glycolytic and oxidative metabolism alterations in AD.
Approach: Mice expressing mutant human tau (P301S) and human APOE4 (TE4 model), or expressing only human APOE4, underwent hyperpolarized 13C MRS and T2/T1-weighted MRI to investigate metabolic and volumetric changes.
Results: Hyperpolarized 13C MRS detects lower [13C]bicarbonate production in the tauopathy model, indicating impaired oxidative metabolism and mitochondrial dysfunction. T2/T1-weighted MRI confirmed brain neurodegeneration and blood-brain-barrier leakiness in this model.
Impact: We demonstrated that hyperpolarized 13C MRS has potential to monitor impaired oxidative metabolism in the brain of a clinically relevant AD model. Upon clinical translation, this method could improve diagnosis and monitoring of AD progression, and the assessment of therapies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords